Examples include the downregulation/loss of CD19 antigen in B-cell acute lymphoblastic leukemia as well as the downregulation or loss of B-cell maturation antigen expression in multiple myeloma leading to resistance against chimeric antigen receptor T-cell therapy [16]. The gene discussed is CD19; the disease is B-cell acute lymphoblastic leukemia.